173 related articles for article (PubMed ID: 10583256)
1. Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura.
Wright JF; Wang H; Hornstein A; Hogarth M; Mody M; Garvey MB; Blanchette V; Rock G; Freedman J
Br J Haematol; 1999 Dec; 107(3):546-55. PubMed ID: 10583256
[TBL] [Abstract][Full Text] [Related]
2. Minimal evidence of platelet and endothelial cell reactive antibodies in thrombotic thrombocytopenic purpura.
Raife TJ; Atkinson B; Aster RH; McFarland JG; Gottschall JL
Am J Hematol; 1999 Oct; 62(2):82-7. PubMed ID: 10509001
[TBL] [Abstract][Full Text] [Related]
3. Association of autoantibodies against platelet glycoproteins Ib/IX and IIb/IIIa, and platelet-reactive anti-HIV antibodies in thrombocytopenic narcotic addicts.
Gonzalez-Conejero R; Rivera J; Rosillo MC; Cano A; Rodriguez T; Vicente V
Br J Haematol; 1996 May; 93(2):464-71. PubMed ID: 8639450
[TBL] [Abstract][Full Text] [Related]
4. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
5. Fab-mediated binding of glycoprotein Ib/IX and IIb/IIIa specific antibodies in chronic idiopathic thrombocytopenic purpura.
Hou M; Stockelberg D; Kutti J; Wadenvik H
Br J Haematol; 1995 Dec; 91(4):944-50. PubMed ID: 8547147
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against platelet GPIb/IX, GPIIb/IIIa, and other platelet antigens in chronic idiopathic thrombocytopenic purpura.
Hou M; Stockelberg D; Kutti J; Wadenvik H
Eur J Haematol; 1995 Nov; 55(5):307-14. PubMed ID: 7493677
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure.
Semple JW; Siminovitch KA; Mody M; Milev Y; Lazarus AH; Wright JF; Freedman J
Br J Haematol; 1997 Jun; 97(4):747-54. PubMed ID: 9217172
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
Tandon NN; Rock G; Jamieson GA
Br J Haematol; 1994 Dec; 88(4):816-25. PubMed ID: 7529543
[TBL] [Abstract][Full Text] [Related]
9. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation.
Jimenez JJ; Jy W; Mauro LM; Horstman LL; Soderland C; Ahn YS
Br J Haematol; 2003 Dec; 123(5):896-902. PubMed ID: 14632781
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of TTP sera on binding of anti-platelet glycoprotein IIb-IIIa monoclonal antibodies to human vascular endothelial cells.
Nakajima T; Koyama T; Kakishita E; Nagai K
Am J Hematol; 1987 May; 25(1):115-8. PubMed ID: 3578260
[TBL] [Abstract][Full Text] [Related]
11. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Murphy WG
Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
[TBL] [Abstract][Full Text] [Related]
12. Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms complexes with platelet membrane glycoprotein IV (CD36).
Siddiqui FA; Lian EC
Biochem Int; 1992 Jul; 27(3):485-96. PubMed ID: 1384492
[TBL] [Abstract][Full Text] [Related]
13. Redistribution of membrane glycoproteins in platelets activated under flow conditions.
Lozano M; Escolar G; White JG; Tàssies D; Ordinas A; Díaz-Ricart M
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):214-7. PubMed ID: 8735822
[TBL] [Abstract][Full Text] [Related]
14. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib.
Walsh MT; Dinan TG; Condren RM; Ryan M; Kenny D
Life Sci; 2002 May; 70(26):3155-65. PubMed ID: 12008098
[TBL] [Abstract][Full Text] [Related]
15. Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients.
Grodzicky T; Bussel JB; Elkon KB
Clin Exp Immunol; 2002 Feb; 127(2):289-92. PubMed ID: 11876752
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies.
Hou M; Stockelberg D; Kutti J; Wadenvik H
Br J Haematol; 1997 Jul; 98(1):64-7. PubMed ID: 9233565
[TBL] [Abstract][Full Text] [Related]
17. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.
Jimenez JJ; Jy W; Mauro LM; Horstman LL; Ahn YS
Br J Haematol; 2001 Jan; 112(1):81-90. PubMed ID: 11167788
[TBL] [Abstract][Full Text] [Related]
18. Studies of the pathogenesis and management of thrombotic thrombocytopenic purpura.
Kakishita E; Nakajima T; Suehiro A; Koyama T; Ueda M; Tsujioka H; Yoshimoto H
Pol J Pharmacol; 1996; 48(2):179-84. PubMed ID: 9112648
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic autoimmune thrombocytopenia: evidence for redistribution of platelet antibodies into the circulation after immunoadsorption treatment.
Leitner GC; Stiegler G; Horvath M; Hoecker P; Sagaster P; Panzer S
Am J Hematol; 2003 May; 73(1):44-7. PubMed ID: 12701120
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
